作者: 中子 時(shí)間: 2025-3-21 21:48 作者: –DOX 時(shí)間: 2025-3-22 02:53 作者: Mri485 時(shí)間: 2025-3-22 06:13
Anticoagulation in CKDrdial infarction, prosthetic valve replacement, and prevention and treatment of venous thromboembolism. The risk of stroke in patients with stage 3 CKD and end-stage renal disease (ESRD) is higher than that of the general population and, in combination with atrial fibrillation, necessitates oral ant作者: Exclaim 時(shí)間: 2025-3-22 11:42
MRA Inhibition in CKD: More Than Salt and Watermost important causes of CKD in developed countries are diabetic nephropathy and renovascular disease/hypertension. Despite a proven favorable effect of RAAS blockade on short-term parameters (blood pressure, proteinuria) as well as long term outcome (slower decline of GFR), progression of chronic k作者: extinguish 時(shí)間: 2025-3-22 14:18 作者: extinguish 時(shí)間: 2025-3-22 19:37
Uric Acid, Allopurinol: The Cardio-Renal Silver Bullet?scular events. Uric acid is the end product of purine metabolism that circulates in the plasma at concentrations varying from 2 to 10 mg/dl or higher. Purine nucleotides are derived from both exogenous (alimentary intake, especially animal proteins) and endogenous sources (. molecule synthesis and n作者: BARK 時(shí)間: 2025-3-23 00:05
FGF23 and Phosphate: Two Cardiovascular Toxins with Distinct Toxicity Profiles?n integral element of CRS-4 is dysregulated mineral metabolism including altered serum levels of calcium and inorganic phosphorus (Pi). Downstream biochemical consequences entail remarkable elevations in the principal hormones regulating serum calcium and Pi, including parathyroid hormone (PTH), and作者: 不安 時(shí)間: 2025-3-23 05:10 作者: 微不足道 時(shí)間: 2025-3-23 08:31
Effect of Vitamin D on Endothelial Function and Blood Pressurers and is increasingly associated with non-traditional risk factors [2]. Vitamin D deficiency is a non-traditional risk factor for cardiovascular events which becomes more relevant with declining renal function. At the same time, the deficiency of active vitamin D plays a major role in the mineral-b作者: Leisureliness 時(shí)間: 2025-3-23 13:00
Vitamin D and Its Effects on the Heartmmetric left ventricular hypertrophy, chronic kidney disease Stage 3B presents in follow up of his multiple cardiovascular issues. He has a normal serum calcium level and his parathyroid hormone is within target range. Would this patient benefit of vitamin D treatment and if so, which form and dose 作者: 斗志 時(shí)間: 2025-3-23 14:00 作者: 兵團(tuán) 時(shí)間: 2025-3-23 18:44
Pulmonary Hypertension in CKD: A New Problem Childt diseases and several CKD-specific risk factors, including the presence of artero-venous fistula, fluid overload, sleep breathing disorders and the exposure to dialysis membranes, can be implicated at various level in the genesis of PH in the CKD population. PH in CKD is a potentially reversible pr作者: indubitable 時(shí)間: 2025-3-24 00:38
How to Use Inhibitors of the Renin-Angiotensin-Aldosterone System in Patients with CKD and Heart Failining kidney function [1]. In the Atherosclerosis Risk in Communities (ARIC) Study [2], a large, population-based study of U.S. adults, the incidence of HF was three-fold higher in individuals with an estimated glomerular filtration rate (GFR) <60 mL/min/1.73 m., compared with the reference group w作者: 極大的痛苦 時(shí)間: 2025-3-24 06:17
Erectile and Sex Hormone Dysfunction and Cardiovascular Consequences in CKDempts have been made to implement ED in well-known CV risk scoring systems. ED has been described as just one manifestation of the generalized atherosclerosis syndrome, similar to angina pectoris. Interestingly ED appears a few years before other clinical manifestations of cardiac disease, particula作者: Flu表流動(dòng) 時(shí)間: 2025-3-24 09:31 作者: 笨拙的我 時(shí)間: 2025-3-24 14:15 作者: Macronutrients 時(shí)間: 2025-3-24 17:58
https://doi.org/10.1007/978-3-319-09162-4Anticoagulation; Arrhythmia; Arterial Stiffening; CKD; CVD; Calcification; Cardio-renal; Cardiovascular Dis作者: Chivalrous 時(shí)間: 2025-3-24 20:33
978-3-319-34870-4Springer International Publishing Switzerland 2015作者: 有角 時(shí)間: 2025-3-25 01:10 作者: 迎合 時(shí)間: 2025-3-25 03:52
,Spezielle Unf?lle und Verletzungen,ity has emerged as one of the major healthcare challenges afflicting the populations of developed and developing countries alike. In the clinic setting, obesity is seldom seen in isolation; rather it is often encountered together with diabetes mellitus, or impaired glucose homeostasis, and hypertens作者: 漫不經(jīng)心 時(shí)間: 2025-3-25 10:59
,Notfallmedikame und Infusionsl?sunqen,ause of death in hemodialysis patients in the USA, accounting for 26 % of all cause mortality. The very high rate of cardiovascular death and the substantial contribution of SCD to these rates in patients with CKD and ESRD is not fully explained by the high prevalence of traditional cardiac risk fac作者: Canyon 時(shí)間: 2025-3-25 12:33
Atemwegssicherung, Intubation und Beatmung,rdial infarction, prosthetic valve replacement, and prevention and treatment of venous thromboembolism. The risk of stroke in patients with stage 3 CKD and end-stage renal disease (ESRD) is higher than that of the general population and, in combination with atrial fibrillation, necessitates oral ant作者: 拍翅 時(shí)間: 2025-3-25 17:24 作者: 干涉 時(shí)間: 2025-3-25 23:01 作者: 四海為家的人 時(shí)間: 2025-3-26 03:23 作者: condone 時(shí)間: 2025-3-26 06:31 作者: infelicitous 時(shí)間: 2025-3-26 10:56
,Notfallmedikame und Infusionsl?sunqen,ronic HF, deterioration of kidney function usually occurs. The cause of this deterioration is much more complex than first thought and represents a combination of various pathophysiological pathways. Apart from low cardiac output (forward failure), tubuloglomerular feedback and increased intraabdomi作者: 不適 時(shí)間: 2025-3-26 14:17 作者: rods366 時(shí)間: 2025-3-26 20:04
,Grundlegende notfallmedizinische Ma?nahmen,mmetric left ventricular hypertrophy, chronic kidney disease Stage 3B presents in follow up of his multiple cardiovascular issues. He has a normal serum calcium level and his parathyroid hormone is within target range. Would this patient benefit of vitamin D treatment and if so, which form and dose 作者: VOK 時(shí)間: 2025-3-26 22:33
,Grundlegende notfallmedizinische Ma?nahmen, to the recognition that additional characteristics of the heart and vasculature play a crucial role in the pathogenesis of cardiovascular disease. Possibly the most prominent feature is arterial stiffness. Although being an inevitable consequence of aging and inseparable phenomenon with hypertensio作者: GOAT 時(shí)間: 2025-3-27 04:26
,Gastrointestinale und abdominale Notf?lle,t diseases and several CKD-specific risk factors, including the presence of artero-venous fistula, fluid overload, sleep breathing disorders and the exposure to dialysis membranes, can be implicated at various level in the genesis of PH in the CKD population. PH in CKD is a potentially reversible pr作者: Ataxia 時(shí)間: 2025-3-27 05:52
,Grundlegende notfallmedizinische Ma?nahmen,lining kidney function [1]. In the Atherosclerosis Risk in Communities (ARIC) Study [2], a large, population-based study of U.S. adults, the incidence of HF was three-fold higher in individuals with an estimated glomerular filtration rate (GFR) <60 mL/min/1.73 m., compared with the reference group w作者: 勉勵(lì) 時(shí)間: 2025-3-27 09:35
,Gastrointestinale und abdominale Notf?lle,empts have been made to implement ED in well-known CV risk scoring systems. ED has been described as just one manifestation of the generalized atherosclerosis syndrome, similar to angina pectoris. Interestingly ED appears a few years before other clinical manifestations of cardiac disease, particula作者: Nutrient 時(shí)間: 2025-3-27 13:57 作者: Suppository 時(shí)間: 2025-3-27 19:28 作者: FRONT 時(shí)間: 2025-3-28 01:47
David Goldsmith,Adrian Covic,Jonas SpaakDiscusses the evidence for best management of chronic kidney disease (CKD) in the context of cardiorenal syndrome (CRS), as well as the reasons for the complex interplay between the cardiac and renal 作者: 異端邪說(shuō)2 時(shí)間: 2025-3-28 04:16
http://image.papertrans.cn/c/image/221855.jpg作者: 反叛者 時(shí)間: 2025-3-28 09:06 作者: Kinetic 時(shí)間: 2025-3-28 11:02
Volume Overload in CKD: Pathophysiology, Assessment Techniques, Consequences and Treatment‘Fluid balance’ is generally defined by the difference between the daily fluid input and the daily fluid output and it should not be associated with weight and insensible losses, but it could be correlated with dialysis fluid removal if an individual is on renal replacement therapy (RRT) [1].作者: Ptosis 時(shí)間: 2025-3-28 15:53
MRA Inhibition in CKD: More Than Salt and Water status and blood pressure. In this chapter we will describe the non-conventional renal and extrarenal effects of aldosterone, and review the effects of mineralocorticoid receptor antagonists in cardiovascular diseases and chronic kidney disease.作者: moribund 時(shí)間: 2025-3-28 20:57 作者: 蒙太奇 時(shí)間: 2025-3-28 23:39 作者: 用手捏 時(shí)間: 2025-3-29 03:22 作者: myelography 時(shí)間: 2025-3-29 08:44
How to Use Inhibitors of the Renin-Angiotensin-Aldosterone System in Patients with CKD and Heart FaiRD) patients had HF at initiation of dialysis and more than half of these manifested recurrence of HF later on, whereas among patients without previous HF, 25 % subsequently developed HF during dialysis. However, the Dialysis Outcomes and Practice Patterns Study (DOPPS) showed considerable geographi作者: inscribe 時(shí)間: 2025-3-29 14:03
Atemwegssicherung, Intubation und Beatmung, status and blood pressure. In this chapter we will describe the non-conventional renal and extrarenal effects of aldosterone, and review the effects of mineralocorticoid receptor antagonists in cardiovascular diseases and chronic kidney disease.作者: LOPE 時(shí)間: 2025-3-29 17:33 作者: Pamphlet 時(shí)間: 2025-3-29 23:32 作者: 消極詞匯 時(shí)間: 2025-3-30 03:14 作者: finale 時(shí)間: 2025-3-30 06:48
,Grundlegende notfallmedizinische Ma?nahmen,RD) patients had HF at initiation of dialysis and more than half of these manifested recurrence of HF later on, whereas among patients without previous HF, 25 % subsequently developed HF during dialysis. However, the Dialysis Outcomes and Practice Patterns Study (DOPPS) showed considerable geographi作者: agenda 時(shí)間: 2025-3-30 09:44 作者: Condense 時(shí)間: 2025-3-30 13:06
ical burden imposed by this link is at the basis of the emergence of a new discipline aiming at making the borders between nephrology and cardiovascular medicine even more permeable than before. The term Cardio978-3-319-34870-4978-3-319-09162-4作者: 防銹 時(shí)間: 2025-3-30 16:54
,Spezielle Unf?lle und Verletzungen,ion, a constellation of diseases defined as the metabolic syndrome. The disease entities under the umbrella of the metabolic syndrome each contribute to small vessel changes that ultimately lead to end organ damage including renal failure.作者: 危險(xiǎn) 時(shí)間: 2025-3-30 21:23
,Grundlegende notfallmedizinische Ma?nahmen,one disease of patients with CKD. The role of vitamin D deficiency in causing cardiovascular complications in the general population has attracted huge attention from researchers in recent years [3]. However, patients with kidney failure deserve further attention due to the role of kidneys in activating vitamin D.作者: PARA 時(shí)間: 2025-3-31 03:59 作者: ELUDE 時(shí)間: 2025-3-31 07:07
Book 2015logy. Nowhere is this more obvious than in the interaction between Chronic Kidney Disease (CKD), Diabetes and diverse CV diseases (CVD). This is a complex and challenging area, as the presence of CKD/diabetes promotes CVD while also complicating its treatment. The emergence of CKD as a public health作者: Cholagogue 時(shí)間: 2025-3-31 09:35 作者: Neonatal 時(shí)間: 2025-3-31 16:17 作者: 不在灌木叢中 時(shí)間: 2025-3-31 20:10
